COVID-19(4) SARS-CoV-2(4) drug treatments(3) COVID-19 pandemic(3) treat(3) lung(3) susceptible(3) Prophylactic(3) Occurrence(3) COVID-19 pathogenesis(3) changes in(3) Inflammatory cytokines(3) Treatment(3) K18-hACE2(3) ramelteon.(3) melatonin(3) therapeutic potential(3) interferons(3) type I and type III interferons(3) Symptom(3) limit(3) Spread(3) exacerbated(3) therapeutic(3) disease(3) dose(3) vaccination(3) type I(3) variant(3) Type III interferons(3)